Optic capture technique prevents PCO after pediatric cataract surgery

Article

Posterior continuous curvilinear capsulorhexis (PCCC) with optic capture of a posterior chamber IOL is a safe and effective technique to afford stable IOL fixation and maintain visual axis clarity after cataract surgery in pediatric eyes.

Posterior continuous curvilinear capsulorhexis (PCCC) with optic capture of a posterior chamber IOL is a safe and effective technique to afford stable IOL fixation and maintain visual axis clarity after cataract surgery in pediatric eyes, reported Ye Ying Jia, MD. Dr. Jia presented the outcomes from 83 eyes operated on between May 2002 and May 2007. The patients ranged in age from 2 to 14 years (mean 5 years).

Cataract removal was achieved by extracapsular cataract extraction (ECCE) through an anterior continuous curvilinear capsulorhexis measuring 6- to 7-mm. The PCCC was oval in shape and measured 3.5- by 4.5-mm. Anterior vitrectomy was not performed.

Optic capture of the PC-IOL was achieved in 79 eyes (95.2%). At 6 months after surgery, best-corrected distance visual acuity was 20/40 or better in about 52% of eyes. After follow-up of 12 to 36 months, all eyes maintained a clear visual axis Complications included early anterior chamber fibrous exudation (23%) that responded to topical anti-inflammatory treatment, limited iris posterior synechia (16%), and superficial IOL deposits.

"Between 75% and 100% of pediatric eyes develop posterior capsule opacification after ECCE. The technique of PCCC with IOL optic capture prevents this phenomenon by creating tighter contact of the IOL with the posterior capsule to prevent migration of lens epithelial cells. A Soemmering's ring is formed, the capsular sac is blocked, and a clear visual axis maintained," said Dr. Jia.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.